Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort
Open Access
- 8 June 2025
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 60 (7) , 716-727
Abstract
Identifying patients at risk of developing severe inflammatory bowel disease (IBD) can aid treatment decisions. However, predicting disease course remains challenging. We aimed to identify predictive factors associated with severe disease course in the first year after IBD diagnosis. Newly diagnosed adult (≥18 years) patients with IBD were recruited from a population-based inception cohort (IBSEN III study). Preselected baseline factors were tested for associations with severe disease course, defined as IBD-related hospitalisation, surgery, treatment with ≥2 steroid courses, >2 biologics and/or new event of complication (stricture, fistula, abscess only applicable Crohn's disease (CD)). From a best fitted multivariable logistic regression model stratified by diagnosis and age (18-40/>40 years), probability of severe disease for given combinations of predictive factors was summarised in prediction matrices. At one-year follow-up, 90/559 (16%) patients with ulcerative colitis (UC) and 74/312 (24%) with CD had severe disease. Treatment with systemic steroids, vitamin D deficiency, Simple Clinical Colitis Activity Index >2, and hypoalbuminemia at diagnosis were all significantly associated with severe disease in UC patients. CD patients with stricturing or penetrating disease behaviour, systemic steroids and hypoalbuminemia at diagnosis were associated with severe disease course. The least favourable combination of these factors increased the probability of severe disease from 3% (95%CI[0-5%]) to 72% (95%CI[66-79%]) for UC and from 8% (95%CI[3-13%]) to 88% (95%CI[84-93%]) for CD. Our study identified predictive factors associated with severe disease the first year after diagnosis. The probability of severe disease summarised in matrices enables easy risk stratification.Keywords
This publication has 48 references indexed in Scilit:
- Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn’s Disease but Not in Ulcerative ColitisClinical Gastroenterology and Hepatology, 2022
- Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL studyInternational Journal of Colorectal Disease, 2022
- Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly PredictableClinical Gastroenterology and Hepatology, 2021
- Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk modelInternational Journal of Colorectal Disease, 2019
- Vitamin D deficiency in adult patients with ulcerative colitis: Prevalence and relationship with disease severity, extent, and durationIndian Journal of Gastroenterology, 2019
- Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitisCytokine, 2018
- Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's diseaseJournal of Crohn's and Colitis, 2013
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialThe Lancet, 2008
- Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up StudyClinical Gastroenterology and Hepatology, 2007
- Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDGastrointestinal Endoscopy, 2004